0

LBQ657

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP149709444
CAS149709-44-4
MDL NumberMFCD00921225
Molecular Weight383.44
Description≥97% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥97% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

Thomas G von Lueder, Bing H Wang, Andrew R Kompa, Li Huang, Randy Webb, Pierre Jordaan, Dan Atar, Henry Krum

Circ Heart Fail. 2015 Jan;8(1):71-8.

PMID: 25362207

1

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

Scott A Hubers, Nancy J Brown

Circulation. 2016 Mar 15;133(11):1115-24.

PMID: 26976916

1

Effects of Age and Sex on the Pharmacokinetics of LCZ696, an Angiotensin Receptor Neprilysin Inhibitor

Lu Gan, Thomas Langenickel, Jesika Petruck, Kiran Kode, Iris Rajman, Priya Chandra, Wei Zhou, Sam Rebello, Gangadhar Sunkara

J Clin Pharmacol. 2016 Jan;56(1):78-86.

PMID: 26073563

1

Long-term Neprilysin Inhibition - Implications for ARNIs

Duncan J Campbell

Nat Rev Cardiol. 2017 Mar;14(3):171-186.

PMID: 27974807

1

The Angiotensin II Type 1 Receptor-Neprilysin Inhibitor LCZ696 Blocked Aldosterone Synthesis in a Human Adrenocortical Cell Line

Shin-Ichiro Miura, Yasunori Suematsu, Yoshino Matsuo, Sayo Tomita, Asuka Nakayama, Masaki Goto, Tadaaki Arimura, Takashi Kuwano, Eiji Yahiro, Keijiro Saku

Hypertens Res. 2016 Nov;39(11):758-763.

PMID: 27334058

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode